Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases
Provided herein are antisense oligomers comprising a chemically modified antisense oligomer having a targeting sequence that is complementary to a target region of the human peripheral myelin protein 22 (PMP22) pre-mRNA. The antisense oligomer can be a peptide nucleic acid, a locked nucleic acid, ph...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MORGAN, KATHY AUNG-HTUT, MAY THANDAR MALMBERG, ANNIKA KIM, KEVIN WILTON, STEPHEN DONALD |
| description | Provided herein are antisense oligomers comprising a chemically modified antisense oligomer having a targeting sequence that is complementary to a target region of the human peripheral myelin protein 22 (PMP22) pre-mRNA. The antisense oligomer can be a peptide nucleic acid, a locked nucleic acid, phosphorodiamidate morpholino oligomer, a 2'-O-Me phosphorothioate oligomer, or a combination thereof. In an embodiment, the antisense oligomer is covalently linked to a cell-penetrating peptide. The antisense oligomers are useful for the treatment for various diseases in a subject in need thereof, including, but not limited to, a disease associated with dysregulation of peripheral myelin protein 22. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202325846A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202325846A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202325846A3</originalsourceid><addsrcrecordid>eNqNyjEKAjEQRuE0FqLeYTyAIFkVWxHFxsoFy2Vw_7iBJBMmaby9KTyAzfuaNzePu2ieJPgk1PqWCC3kRKkquEakSuIoQ32eoBwoftBuyioVTWtJEbhipNEXcEFZmpnjULD6uTDr66U_3zbIMqBkfiGhDv3Tbm1n98fd4dT983wBloA45w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases</title><source>esp@cenet</source><creator>MORGAN, KATHY ; AUNG-HTUT, MAY THANDAR ; MALMBERG, ANNIKA ; KIM, KEVIN ; WILTON, STEPHEN DONALD</creator><creatorcontrib>MORGAN, KATHY ; AUNG-HTUT, MAY THANDAR ; MALMBERG, ANNIKA ; KIM, KEVIN ; WILTON, STEPHEN DONALD</creatorcontrib><description>Provided herein are antisense oligomers comprising a chemically modified antisense oligomer having a targeting sequence that is complementary to a target region of the human peripheral myelin protein 22 (PMP22) pre-mRNA. The antisense oligomer can be a peptide nucleic acid, a locked nucleic acid, phosphorodiamidate morpholino oligomer, a 2'-O-Me phosphorothioate oligomer, or a combination thereof. In an embodiment, the antisense oligomer is covalently linked to a cell-penetrating peptide. The antisense oligomers are useful for the treatment for various diseases in a subject in need thereof, including, but not limited to, a disease associated with dysregulation of peripheral myelin protein 22.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230701&DB=EPODOC&CC=TW&NR=202325846A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230701&DB=EPODOC&CC=TW&NR=202325846A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MORGAN, KATHY</creatorcontrib><creatorcontrib>AUNG-HTUT, MAY THANDAR</creatorcontrib><creatorcontrib>MALMBERG, ANNIKA</creatorcontrib><creatorcontrib>KIM, KEVIN</creatorcontrib><creatorcontrib>WILTON, STEPHEN DONALD</creatorcontrib><title>Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases</title><description>Provided herein are antisense oligomers comprising a chemically modified antisense oligomer having a targeting sequence that is complementary to a target region of the human peripheral myelin protein 22 (PMP22) pre-mRNA. The antisense oligomer can be a peptide nucleic acid, a locked nucleic acid, phosphorodiamidate morpholino oligomer, a 2'-O-Me phosphorothioate oligomer, or a combination thereof. In an embodiment, the antisense oligomer is covalently linked to a cell-penetrating peptide. The antisense oligomers are useful for the treatment for various diseases in a subject in need thereof, including, but not limited to, a disease associated with dysregulation of peripheral myelin protein 22.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKAjEQRuE0FqLeYTyAIFkVWxHFxsoFy2Vw_7iBJBMmaby9KTyAzfuaNzePu2ieJPgk1PqWCC3kRKkquEakSuIoQ32eoBwoftBuyioVTWtJEbhipNEXcEFZmpnjULD6uTDr66U_3zbIMqBkfiGhDv3Tbm1n98fd4dT983wBloA45w</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>MORGAN, KATHY</creator><creator>AUNG-HTUT, MAY THANDAR</creator><creator>MALMBERG, ANNIKA</creator><creator>KIM, KEVIN</creator><creator>WILTON, STEPHEN DONALD</creator><scope>EVB</scope></search><sort><creationdate>20230701</creationdate><title>Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases</title><author>MORGAN, KATHY ; AUNG-HTUT, MAY THANDAR ; MALMBERG, ANNIKA ; KIM, KEVIN ; WILTON, STEPHEN DONALD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202325846A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MORGAN, KATHY</creatorcontrib><creatorcontrib>AUNG-HTUT, MAY THANDAR</creatorcontrib><creatorcontrib>MALMBERG, ANNIKA</creatorcontrib><creatorcontrib>KIM, KEVIN</creatorcontrib><creatorcontrib>WILTON, STEPHEN DONALD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MORGAN, KATHY</au><au>AUNG-HTUT, MAY THANDAR</au><au>MALMBERG, ANNIKA</au><au>KIM, KEVIN</au><au>WILTON, STEPHEN DONALD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases</title><date>2023-07-01</date><risdate>2023</risdate><abstract>Provided herein are antisense oligomers comprising a chemically modified antisense oligomer having a targeting sequence that is complementary to a target region of the human peripheral myelin protein 22 (PMP22) pre-mRNA. The antisense oligomer can be a peptide nucleic acid, a locked nucleic acid, phosphorodiamidate morpholino oligomer, a 2'-O-Me phosphorothioate oligomer, or a combination thereof. In an embodiment, the antisense oligomer is covalently linked to a cell-penetrating peptide. The antisense oligomers are useful for the treatment for various diseases in a subject in need thereof, including, but not limited to, a disease associated with dysregulation of peripheral myelin protein 22.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202325846A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Morpholino oligomers for treatment of peripheral myelin protein 22 related diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A34%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MORGAN,%20KATHY&rft.date=2023-07-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202325846A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |